Churchill Capital Corp VII
CVII

$10.79

0.09%

Market Cap: 988M

About: Churchill Capital Corp VII is a blank check company.

Employees: 2

Financials Blank Checks

0

Funds holding %

of 6,702 funds

–

Analysts bullish %

–

News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

1% more capital invested

Capital invested by funds: $592M [Q4 2023] → $595M (+$3.47M) [Q1 2024]

1.36% less ownership

Funds ownership: 97.21% [Q4 2023] → 95.85% (-1.36%) [Q1 2024]

12% less funds holding

Funds holding: 58 [Q4 2023] → 51 (-7) [Q1 2024]

25% less funds holding in top 10

Funds holding in top 10: 8 [Q4 2023] → 6 (-2) [Q1 2024]

39% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 18

72% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 18

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $171K

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for CVII.

See Analyst Rankings

Financial journalist opinion

Special Meeting of Churchill VII Stockholders to Approve Business Combination with CorpAcq and Public Warrant Holder Meeting to Approve Warrant Amendment to be Adjourned and Reconvened for August 12, 2024

Redemption deadline for stockholders moved to August 8, 2024 NEW YORK , July 18, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill VII") (Nasdaq: CVII), a special purpose acquisition company, announced today that it intends to adjourn each of the special meeting of Churchill VII stockholders (the "Stockholder Special Meeting") and the meeting of Churchill VII warrant holders (the "Warrant Holder Meeting"), which are currently scheduled for July 25, 2024, to be held in connection with the proposed business combination between CorpAcq Holdings Limited ("CorpAcq"), and Churchill VII (the "Business Combination"). The Stockholder Special Meeting will reconvene on August 12, 2024 at 10:00 A.M.

Special Meeting of Churchill VII Stockholders to Approve Business Combination with CorpAcq and Public Warrant Holder Meeting to Approve Warrant Amendment to be Adjourned and Reconvened for August 12, 2024

Special Meeting of Churchill Capital Corp VII Stockholders to Approve Business Combination with CorpAcq and Public Warrant Holder Meeting to Approve Warrant Amendment Scheduled for July 25, 2024

Board of Directors Recommends Stockholders and Public Warrant Holders Vote "FOR" All Proposals NEW YORK and ALTRINCHAM, England , June 20, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill VII") (Nasdaq: CVII), a special purpose acquisition company, announced today that it has scheduled a special meeting of Churchill VII stockholders (the "Stockholder Special Meeting") to be held in connection with the proposed business combination (the "Business Combination") between CorpAcq Holdings Limited ("CorpAcq"), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, and Churchill VII and a meeting of Churchill VII public warrant holders (the "Warrant Holder Meeting"), each for July 25, 2024. Churchill VII stockholders and public warrant holders of record as of the close of business on June 18, 2024 (the "Record Date") will receive the definitive proxy statement/prospectus, once available (the "Proxy Statement") relating to the offer of the securities to be issued by CorpAcq Group Plc to Churchill VII's stockholders and public warrant holders in connection with the completion of the Business Combination by mail and are entitled to vote at the Stockholder Special Meeting and/or Warrant Holder Meeting, respectively.

Special Meeting of Churchill Capital Corp VII Stockholders to Approve Business Combination with CorpAcq and Public Warrant Holder Meeting to Approve Warrant Amendment Scheduled for July 25, 2024

Special Meeting of Churchill Capital Corp VII Stockholders to Approve Business Combination with CorpAcq and Warrant Holder Meeting to Approve Warrant Amendment Scheduled for May 21, 2024

Board of Directors Recommends Stockholders and Warrant Holders Vote "FOR" All Proposals NEW YORK and ALTRINCHAM, England , March 22, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill VII") (Nasdaq: CVII), a special purpose acquisition company, announced today that it has scheduled a special meeting of Churchill VII stockholders and a meeting of Churchill VII warrant holders for May 21, 2024 in connection with the proposed business combination between CorpAcq Holdings Limited ("CorpAcq"), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, and Churchill VII (the "Business Combination"). The Business Combination continues to progress and is expected to be completed in the first half of 2024.

Special Meeting of Churchill Capital Corp VII Stockholders to Approve Business Combination with CorpAcq and Warrant Holder Meeting to Approve Warrant Amendment Scheduled for May 21, 2024

Churchill Capital Corp VII Announces Stockholder Approval of Extension and Final Redemption Numbers

In Excess of $605 Million Remains in Churchill VII's Trust Account after Stockholder Redemptions relating to the Extension NEW YORK , Feb. 12, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill VII") (NASDAQ: CVII) announced today that in a special meeting of its stockholders ("Special Meeting"), Churchill VII's stockholders voted to approve a proposal to amend Churchill VII's certificate of incorporation and extend the date by which Churchill VII is required to consummate its initial business combination (the "Business Combination") with CorpAcq Holdings Limited ("CorpAcq") from February 17, 2024 to August 17, 2024 (or such earlier date as determined by the board of directors of Churchill VII). All other proposals were also approved with overwhelming support from Churchill VII's stockholders.

Churchill Capital Corp VII Announces Stockholder Approval of Extension and Final Redemption Numbers

Churchill Capital Corp VII Announces Continuation of $1,000,000 Monthly Sponsor Contribution

Special meeting of stockholders of Churchill VII scheduled for February 8, 2024 to extend date by which Churchill VII must consummate its business combination with CorpAcq Holdings Limited NEW YORK , Jan. 30, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill VII") announced today actions being undertaken in advance of a special meeting of its stockholders (the "Special Meeting") on February 8, 2024, at which Churchill VII's stockholders will be asked to vote on, among other things, a proposal to amend Churchill VII's amended and restated certificate of incorporation to extend the date by which Churchill VII has to consummate its business combination with CorpAcq Holdings Limited ("CorpAcq") from February 17, 2024 to August 17, 2024 or such earlier date as determined by the Churchill VII board of directors (the "Board") (the "Extension Amendment Proposal"). Churchill VII Sponsor Seeking Extension to Pursue a Business Combination with CorpAcq Holdings Limited As previously disclosed, on August 1, 2023, Churchill VII entered into a definitive agreement for a business combination (and together with the transactions contemplated thereby, the "Transactions") with CorpAcq, a corporate compounder with a proven track record of acquiring and supporting founder-led businesses.

Churchill Capital Corp VII Announces Continuation of $1,000,000 Monthly Sponsor Contribution

Churchill Capital Corp VII Announces Intention to Transfer Listing to Nasdaq

NEW YORK , Jan. 23, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill VII") (NYSE: CVII), a special purpose acquisition company, announced today that it plans to transfer the listing of its shares of Class A common stock, public warrants and public units from the New York Stock Exchange ("NYSE") to Nasdaq Global Market ("Nasdaq"). Churchill VII expects that listing and trading of its securities on the NYSE will end at market close on February 2, 2024, and expects to commence trading as a Nasdaq-listed company upon market open on February 5, 2024.

Churchill Capital Corp VII Announces Intention to Transfer Listing to Nasdaq

CorpAcq Reaffirms 2023 Guidance and Provides Business and Refinancing Update

ALTRINCHAM, England and NEW YORK , Jan. 22, 2024 /PRNewswire/ -- CorpAcq Holdings Limited ("CorpAcq"), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, today provided the following business update including: Reaffirming guidance for the full year ending December 31, 2023; Confirming on track timing of its Business Combination with Churchill Capital Corp VII ("Churchill VII") (NYSE: CVII); A successful refinancing of its group debt; and Upcoming Analyst Day. Management Reaffirms Financial Outlook for Full-Year 2023 Since the release of its financials for the first six months of 2023 on November 17, 2023, CorpAcq has continued to maintain its strong and profitable growth trajectory.

CorpAcq Reaffirms 2023 Guidance and Provides Business and Refinancing Update

CorpAcq and Churchill Capital Corp VII Announce Filing of Registration Statement on Form F-4 in Connection with Proposed Business Combination and CorpAcq's First Half 2023 Results

ALTRINCHAM, England and NEW YORK , Nov. 17, 2023 /PRNewswire/ -- CorpAcq Holdings Limited ("CorpAcq"), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, Churchill Capital Corp VII ("Churchill VII") (NYSE: CVII), a special purpose acquisition company, and CorpAcq Group Plc, a public limited company incorporated under the laws of England and Wales ("CorpAcq Group"), announced today the filing of a registration statement of CorpAcq Group on Form F-4 (the "Registration Statement") with the U.S. Securities and Exchange Commission (the "SEC") on November 17, 2023. The Registration Statement contains a proxy statement/prospectus in connection with the definitive agreement entered into between Churchill VII, CorpAcq and CorpAcq Group with respect to the proposed business combination (the "Merger Agreement", and the transactions contemplated thereby, the "Transactions").

CorpAcq and Churchill Capital Corp VII Announce Filing of Registration Statement on Form F-4 in Connection with Proposed Business Combination and CorpAcq's First Half 2023 Results

See News Rankings